TUSTIN, Calif., Dec. 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL - News), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that Mercy Bio Technology Co., Ltd., has received Department of Health approval to market DR-70®, AMDL's non-invasive cancer blood test kit, in Taiwan.
